Navigation Links
Entries Still Open for US Clinical Researcher of the Year 2012 Competition
Date:7/31/2012

LONDON, July 31, 2012 /PRNewswire/ --

There is still time to enter the US Clinical Researcher of the Year competition, whose theme this year focuses on using resources more effectively without compromising patient safety or quality of data.

The competition welcomes participants from the following areas of research:

  • Study Nurse/Clinical Research Coordinator
  • Clinical Research Associates (with varying levels of experience)
  • Project Manager working within a CRO environment
  • Study Leader working within a pharma/sponsor environment
  • Clinical Trial Teams

Entries are building fast with engagement from a broad cross-section of CRO and pharma competitors including: PRA, PPD, Parexel, Chiltern, INC Research, Shire Pharmaceuticals, GSK, Sanofi, Benchmark Research, Endo Pharmaceuticals, MSD, Abbott and Allergan.

Professionals within the clinical research fraternity are able to compete on a level playing field in this competition, working through a series of competency-based exercises that start with a multiple-choice questionnaire based on ICH/GCP and end with a case-study devised to explore different approaches to risk-based or targeted monitoring.

Organised by media company PharmaTimes, the competition is independently judged by a high level Executive Steering Committee drawn from senior pharma clinical leaders within AZ, GSK, MSD, Sanofi, Shire, Endo Pharma, Allergan, Alcon and Stiefel.

Finals day and presentation of the US Clinical Researcher of the Year awards will take place on 8 November and will be hosted by competition sponsors, SAS, at their Executive Briefing Centre in Cary, North Carolina.

Closing date for entry to the competition is 7 September. For more information and/or to enter the competition please go to http://www.usclinicalresearcher.com.

Contacts: Sean Morgan-Jones - +44(0)208-8788566 - email: sean@pharmatimes.com.



'/>"/>
SOURCE Pharma Times
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
3. Disability Advocates Tell Medicare: Use a Clinical Template to Accurately Document Medical Need for Wheelchairs
4. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
5. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
6. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
7. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
8. Berg Pharma launches clinical trial on BPM 31543 for prevention of chemotherapy-induced alopecia (CIA)
9. Caspase Inhibitor Enters Clinical Trial In Islet Transplantation As Treatment For Diabetes
10. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
11. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... -- CaryRx, a next-generation full-service pharmacy, has announced the launch ... the Washington D.C. metropolitan area. CaryRx ... of medications through the convenience of its patient-friendly mobile app. ... one hour to any location in D.C. ... service to Washington D.C. ," says Areo ...
(Date:7/31/2017)... July 31, 2017 7D Surgical, developer of ground ... purchased the 7D Surgical System to support its strategic sales ... D.C. and Virginia.  7D Surgical has entered into ... of the premier medical facilities within those markets. ... ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be ... for the second year in a row. The Inc. 5000 list honors private businesses ... “To be on the list once is a great accomplishment, but for us to ...
(Date:8/16/2017)... ... August 16, 2017 , ... In 1987, McDaniel & Durrett, ... in business this year, and they’re marking the milestone by undertaking a significant ... patients. , It stands to reason that, given the central importance of ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... has received a three-year grant totaling $975,000, renewing its funding from the Health ... Human Services. , This funding marks, the fourth time the HRSA administration has ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... Endoscopes states: “Drying the endoscope after every reprocessing cycle, both between patient procedures ... transmission and nosocomial infections. Drying is as important to the prevention of disease ...
(Date:8/16/2017)... Lake City, Utah (PRWEB) , ... August 16, 2017 , ... ... spot on the Inc 5000 list for the fourth consecutive year. With ... Inc. 5000 2017 list of the nation’s fastest growing companies. , Previous ...
Breaking Medicine News(10 mins):